|
||||||||||
|
||||||||||
|
|
Slide of |
|||||||||
Management of Teratogenic Drugs in Dermatology PatientsTeratogenic Drugs Used in Dermatology
Note that the above lists may not be exhaustive. In many cases the exact risk is not known since no unified database is available. The overall rate of birth defects in the general population is 20-30/1000 births. |
||||||||||
|
All content ©2005-2012 SkinTherapyLetter Canadian Edition |
||||||||||